ENvue Medical, Inc. FEED
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -63.40% | 109.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -63.40% | 109.29% | |||
| Cost of Revenue | -28.67% | 3.81% | |||
| Gross Profit | -383.64% | 85.14% | |||
| SG&A Expenses | 47.37% | -1.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.91% | 9.87% | |||
| Operating Income | -47.51% | -1.39% | |||
| Income Before Tax | -29.35% | 71.45% | |||
| Income Tax Expenses | -106.06% | 107.88% | |||
| Earnings from Continuing Operations | -28.18% | 70.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -28.18% | 70.26% | |||
| EBIT | -47.51% | -1.39% | |||
| EBITDA | -50.40% | -2.70% | |||
| EPS Basic | 71.28% | 44.40% | |||
| Normalized Basic EPS | 30.90% | 40.72% | |||
| EPS Diluted | 71.28% | 44.40% | |||
| Normalized Diluted EPS | 30.90% | 40.72% | |||
| Average Basic Shares Outstanding | 87.21% | 198.65% | |||
| Average Diluted Shares Outstanding | 87.21% | 198.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||